Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-20831.03%
operating margin TTM
-20141.38%
revenue TTM
280.44 Thousand
revenue per share TTM
0.11$
valuation ratios | |
|---|---|
| pe ratio | -4.75 |
| peg ratio | 0.10 |
| price to book ratio | 65.21 |
| price to sales ratio | 239.30 |
| enterprise value multiple | -2.35 |
| price fair value | 65.21 |
profitability ratios | |
|---|---|
| gross profit margin | -34.48% |
| operating profit margin | -20141.38% |
| pretax profit margin | -20831.03% |
| net profit margin | -20831.03% |
| return on assets | -194.67% |
| return on equity | -1637.13% |
| return on capital employed | -644.7% |
liquidity ratios | |
|---|---|
| current ratio | 1.31 |
| quick ratio | 1.31 |
| cash ratio | 0.98 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 14,877.84 |
| cash conversion cycle | -14,877.84 |
| receivables turnover | 0.00 |
| payables turnover | 0.02 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.08 |
| long term debt to capitalization | 0.08 |
| total debt to capitalization | 0.08 |
| interest coverage | 151.71 |
| cash flow to debt ratio | -159.23 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.28 |
| cash per share | 0.83 |
| operating cash flow per share | -2.28 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -159.23 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -1,071.18 |
Frequently Asked Questions
When was the last time AgeX Therapeutics, Inc. (AMEX:AGE) reported earnings?
AgeX Therapeutics, Inc. (AGE) published its most recent earnings results on 13-11-2025.
What is AgeX Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. AgeX Therapeutics, Inc. (AMEX:AGE)'s trailing twelve months ROE is -1637.13%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. AgeX Therapeutics, Inc. (AGE) currently has a ROA of -194.67%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AGE's net profit margin stand at?
AGE reported a profit margin of -20831.03% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AGE's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.31 in the most recent quarter. The quick ratio stood at 1.31, with a Debt/Eq ratio of 0.08.